Recombinant Human Cystatin C

• Cat.No.: CST3-2713H
• Product Overview: Recombinant Human Cystatin C is expressed inPichia pastoris.

Specification

• Cat. No.: CST3-2713H
• Description: Native Cystatin C in human urine is found in two different forms: one with pI 9.2 and the other with pI 7.8 by elimination of small basic peptides or amino acids from the N-terminal end of protein. Cystatin C has been studied for its role in predicting newonset or deteriorating cardiovascular disease. This cytokine is produced in a serum-free, chemically defined media.
• Source: Pichia pastoris.
• Product Presentation: Single homogenous batch supplied lyophilised from 0.02M NH4HCO3. May contain traces of buffer salts.
• Starting Material: Expressed from Pichia pastoris. N-Terminal sequence confirms first eight amino acids as: SSPGKPPR.
• Purity: Nominally greater than 98% of the protein is Cystatin C.
• Reconstitution: Use of a pH neutral buffer is recommended.
• Storage: Store at 2-8°C (short term). Store <-15°C (long term).

Gene Information

• Gene Name: CST3 cystatin C [ Homo sapiens ]
• Synonyms: CST3; cystatin C; ARMD11; MGC117328; CST3; cystatin C (amyloid angiopathy and cerebral hemorrhage); cystatin C1; cystatin 3; Neuroendocrine basic polypeptide2; OTTHUMP000001641822; ARMD112; post-gamma-globulin; bA218C14.4 (cystatin C); OTTHUMP00000164181; Gamma-trace; gamma-trace; Post-gamma-globulin; MGC117328; Cystatin-3
• Gene ID: 1471
• mRNA Refseq: NM_000099
• Protein Refseq: NP_000090
• MIM: 604312
• UniProt ID: P01034
• Chromosome Location: 20p11.21
• Function: beta-amyloid binding; cysteine-type endopeptidase inhibitor activity; peptidase inhibitor activity; protease binding; protein binding